Hypercvad Plus Imatinib or Dasatinib for Patients with Lymphoid Blastic Phase of Chronic Myeloid Leukemia

被引：0
|
作者：
Strati, Paolo [1 ]
Kantarjian, Hagop M. [1 ]
Thomas, Deborah A. [1 ]
O'Brien, Susan M. [1 ]
Jabbour, Elias J. [1 ]
Quintas-Cardama, Alfonso [1 ]
Borthakur, Gautam [1 ]
Faderl, Stefan [1 ]
Ravandi, Farhad [1 ]
Cortes, Jorge E. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.3766.3766
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3766
引用
收藏
页数：2
相关论文
共 50 条
  • [1] HCVAD Plus Imatinib or Dasatinib in Lymphoid Blastic Phase Chronic Myeloid Leukemia
    Strati, Paolo
    Kantarjian, Hagop
    Thomas, Deborah
    O'Brien, Susan
    Konoplev, Sergej
    Jorgensen, Jeffrey L.
    Luthra, Raja
    Abruzzo, Lynne
    Jabbour, Elias
    Quintas-Cardama, Alfonso
    Borthakur, Gautam
    Faderl, Stefan
    Ravandi, Farhad
    Cortes, Jorge
    CANCER, 2014, 120 (03) : 373 - 380
  • [2] DASATINIB TREATMENT OF IMATINIB-RESISTANT AND IMATINIB-INTOLERANT PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN A CHRONIC PHASE
    Vinogradova, O. Yu.
    Turkina, A. G.
    Vorontsova, A. V.
    Chelysheva, E. Yu.
    Gusarova, G. A.
    Kuznetsov, S. V.
    Goryacheva, S. R.
    Sokolova, M. A.
    Abakumov, E. M.
    Stakhina, O. V.
    Domracheva, E. V.
    Misyurin, A. V.
    Khoroshko, N. D.
    TERAPEVTICHESKII ARKHIV, 2009, 81 (07) : 41 - 46
  • [3] CHRONIC MYELOID LEUKEMIA TREATMENT IN BLASTIC PHASE WITH IMATINIB 600 MG
    Ionita, H.
    Ionita, I.
    Pacurar, R.
    Cheveresan, L.
    Ionita, C. O.
    Cheveresan, M.
    Nicola, D. E.
    Ionita, M.
    Oros, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 544 - 544
  • [4] Imatinib mesylate in blastic phase of chronic myeloid leukemia: an Indian experience
    Mukhopadhyay, S
    Gupta, P
    Saha, K
    Barman, B
    Sen, A
    Mukhopadhyay, A
    ANNALS OF ONCOLOGY, 2005, 16 : 303 - 304
  • [5] Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phase
    Giles, F. J.
    Kantarjian, H. M.
    le Coutre, P. D.
    Baccarani, M.
    Mahon, F-X
    Blakesley, R. E.
    Gallagher, N. J.
    Gillis, K.
    Goldberg, S. L.
    Larson, R. A.
    Hochhaus, A.
    Ottmann, O. G.
    LEUKEMIA, 2012, 26 (05) : 959 - 962
  • [6] Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phase
    F J Giles
    H M Kantarjian
    P D le Coutre
    M Baccarani
    F-X Mahon
    R E Blakesley
    N J Gallagher
    K Gillis
    S L Goldberg
    R A Larson
    A Hochhaus
    O G Ottmann
    Leukemia, 2012, 26 : 959 - 962
  • [7] Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib
    Cortes, Jorge E.
    Khoury, Hanna J.
    Kantarjian, Hagop M.
    Lipton, Jeff H.
    Kim, Dong-Wook
    Schafhausen, Philippe
    Matczak, Ewa
    Leip, Eric
    Noonan, Kay
    Bruemmendorf, Tim H.
    Gambacorti-Passerini, Carlo
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (12) : 1206 - 1214
  • [8] Dasatinib therapy of patients with chronic myeloid leukemia resistant to imatinib therapy
    Khoroshko, N. D.
    Vinogradova, O. Yu.
    Turkina, A. G.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2008, 53 (03): : 29 - 34
  • [9] Immunoprofile of Patients with Chronic Myeloid Leukemia Treated with Imatinib, Nilotinib or Dasatinib
    Hayashi, Yoshiki
    Nakamae, Hirohisa
    Katayama, Takako
    Nakane, Takahiko
    Koh, Hideo
    Nishimoto, Mitsutaka
    Nakamae, Mika
    Yoshida, Masahiro
    Bingo, Masato
    Okamura, Hiroshi
    Aimoto, Mizuki
    Manabe, Masahiro
    Yoshimura, Takuro
    Inaba, Akiko
    Nanno, Satoshi
    Hagihara, Kiyoyuki
    Nakao, Yoshitaka
    Terada, Yoshiki
    Hino, Masayuki
    BLOOD, 2011, 118 (21) : 1607 - 1607
  • [10] Outcome of Patients With Chronic Myeloid Leukemia in Lymphoid Blastic Phase and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated With Hyper-CVAD and Dasatinib
    Morita, Kiyomi
    Kantarjian, Hagop M.
    Sasaki, Koji
    Issa, Ghayas C.
    Jain, Nitin
    Konopleva, Marina
    Short, Nicholas J.
    Takahashi, Koichi
    DiNardo, Courtney D.
    Kadia, Tapan M.
    Garcia-Manero, Guillermo
    Daver, Naval
    Montalban Bravo, Guillermo
    Cortes, Jorge E.
    Ravandi, Farhad
    Jabbour, Elias
    CANCER, 2021, 127 (15) : 2641 - 2647
12345